Trial Details

TERMINATED
Basic Information
Clinical ID c2875
Identifier NCT02849951
Trial Title A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: LT-02|DRUG: LT-02 Placebo
Participant Information
Sponsor Prometheus Laboratories
City Phoenix
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2016-07
Primary Completion Date 2019-03
Completion Date 2019-08